Crescent Biopharma (CBIO) FCF Margin (2013 - 2026)
Crescent Biopharma (CBIO) posted quarterly FCF Margin of 874.3% for Q1 2026, up 95.97% quarter-over-quarter from 21695.8% in Q2 2022.
Crescent Biopharma (CBIO) FCF Margin (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported FCF Margin for 8 consecutive years, with 874.3% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin changed N/A year-over-year to 874.3%; the TTM figure through Jun 2026 stood at 7085.47% (changed N/A YoY), while the FY2025 annual figure was 668.12%, changed N/A from the prior year.
- FCF Margin grew to 874.3% in Q1 2026 per CBIO's latest filing, from 21695.8% in the prior quarter.
- Across five years, FCF Margin topped out at 874.3% in Q1 2026 and bottomed at 21695.8% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Crescent Biopharma | 1.05 Bn | 875.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -870.74% |
| Jun 30, 2022 | -21,695.80% |
| Dec 31, 2021 | -72,675.25% |
| Sep 30, 2021 | -19,582.49% |
| Jun 30, 2021 | -9,589,105.63% |
| Mar 31, 2021 | -1,338.62% |
| Dec 31, 2020 | -5,968.15% |
| Sep 30, 2020 | -1,152.76% |
| Mar 31, 2020 | -38.98% |
| Sep 30, 2016 | -41,607.50% |
| Dec 31, 2015 | -19,676.90% |
| Sep 30, 2015 | 38,178.15% |
| Jun 30, 2015 | -31.70% |
| Jun 30, 2014 | 60.77% |
| Dec 31, 2013 | -7,205.59% |
| Sep 30, 2013 | -6,521.65% |
| Jun 30, 2013 | -4,959.27% |
| Mar 31, 2013 | -101.99% |